About ATELEVA INC.
Ateleva is developing a minimally invasive airway platform for targeted reinflation and localized treatment of collapsed lung segments in critically ill and surgical patients. The device is investigational and not yet cleared or approved by the FDA.
Development of a minimally invasive airway platform for selective reinflation of collapsed lung segmentsTemporary segmental airway isolationSeamless integration with existing bronchoscopy workflows
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ATELEVA INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.